MorphoSys AG (MPSYY.PK) News Headlines

▮ More

Date

Headline

8/3/2022 4:11:03 PM MorphoSys AG Q2 Earnings Summary

7/26/2022 6:54:03 AM MorphoSys Reports Preliminary Q2 Monjuvi U.S. Sales; Updates 2022 Guidance

7/26/2022 6:16:52 AM MorphoSys Preliminary Q2 Monjuvi U.S. Net Product Sales $23.3 Mln/EUR 21.7 Mln

6/15/2022 9:13:53 AM HIBio To Develop, Commercialize MorphoSys' Felzartamab, And TJ210 Outside Of Greater China

6/15/2022 8:43:08 AM I-Mab Partner MorphoSys Announces License Agreements For Felzartamab And TJ210

6/14/2022 9:50:25 PM MorphoSys, HIBio Reach Agreements For Felzartamab And MOR210

6/14/2022 4:09:51 PM MorphoSys And HIBio Enter Into Equity Participation And License Agreements For Felzartamab And MOR210

6/10/2022 3:30:46 AM MorphoSys Presents Data From Multiple Analyses Of MANIFEST Study

5/18/2022 9:00:41 PM MorphoSys Shareholders Approve All Resolutions Proposed By Its Boards

5/4/2022 4:13:59 PM MorphoSys AG Q1 Loss/share EUR 3.59 Vs. Loss EUR 1.27 Year Ago

5/4/2022 4:09:17 PM MorphoSys AG Q1 Loss Climbs

3/22/2022 10:23:01 PM MorphoSys : Swissmedic Temporarily Approves Minjuvi - Lenalidomid Combination For DLBCL Treatment

3/22/2022 7:19:48 AM Pre-market Movers: ENSV, ZH, POLA, HUSN, MOR…

3/17/2022 3:11:05 AM AKU's Q4 Revenue Up 168%, CPRX Expects 2022 Revenue To Grow 38%-45%, VIRX Awaits NAVAL-1 Trial Data

3/16/2022 4:12:50 PM MorphoSys AG Q4 Loss Rises

3/16/2022 4:11:55 PM MorphoSys Q4 Loss/share EUR 11.16 Vs. Loss EUR 0.50 Year Ago

3/10/2022 9:11:23 PM MorphoSys To Take Charge Of EUR 231 Mln After Consolidation Of Research & Discovery Functions

1/7/2022 2:34:41 AM MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales - Quick Facts

1/7/2022 2:19:31 AM MorphoSys Posts Preliminary 2021 Monjuvi U.S. Net Product Sales Of $79.1 Mln

12/22/2021 7:17:47 AM Pre-market Movers: BRTX, RCAT, AVCT, ACST, DBVT…

Morphosys Ag (MPSYY.PK)